Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.
about
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the StoryHsp90 Inhibitors for the Treatment of Chronic Myeloid LeukemiaHaematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph⁺ pre-B acute lymphoblastic leukaemia.Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death.PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorNew agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals.Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.Proteasome inhibition enhances the efficacy of volasertib-induced mitotic arrest in AML in vitro and prolongs survival in vivoA novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells.
P2860
Q26742078-731EDFB9-3452-4568-A252-69A2951D3D6EQ26771790-79162269-A509-4B6A-A173-57C2D6B4DF18Q33414592-10217347-7E5F-4A67-B306-1896177E4966Q33577628-BD13E10C-EAB7-4EFD-BE1C-0AD79247BD8EQ35591146-B9A457F3-055F-46EF-B723-471A0C87E848Q35951377-93289DA9-9025-423A-BF09-1D95722E9AB3Q35951381-F8366D89-773A-4B05-A42C-E962D9F3F098Q37709023-4A29E23D-25AB-4566-9F12-9242A92A5241Q38707201-169669A4-73EA-4A07-A7B0-9145F18A8F9BQ51681258-8AEDBD81-1B15-4409-97B3-9F067CB8C012
P2860
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@ast
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@en
type
label
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@ast
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@en
prefLabel
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@ast
Combination of bortezomib and ...... r-Abl-positive leukemic cells.
@en
P2093
P2860
P1433
P1476
Combination of bortezomib and ...... cr-Abl-positive leukemic cells
@en
P2093
Andreea Lucia Stancu
Bodvael Pennarun
Ioana Goganau
Octavian Bucur
Rajan Dewar
Roya Khosravi-Far
Stefana Maria Petrescu
P2860
P304
P356
10.1371/JOURNAL.PONE.0077390
P407
P577
2013-10-14T00:00:00Z